Cancer Immunology, Immunotherapy Journal Issues Research Articles in December 2024
November 03, 2024
November 03, 2024
BASEL, Switzerland, Nov. 3 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its December 2024 edition (Vol. 73, Issue 12):
* A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients
* Development and validation of a new tool to estimate early mortality in patients with a . . .
* A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients
* Development and validation of a new tool to estimate early mortality in patients with a . . .